Sectors
ABUS
Arbutus Biopharma Corporation
5.07
38 x 5.06
91 x 5.08
bid
ask
-
0.00
0.09%
02:09 PM
timesize
| Ytd | 5.31% | |
| 1y | 36.53% |
4.99
day range
5.09
3.50
52 week range
5.45
| Open | 5.04 | Prev Close | 5.07 | Low | 4.99 | High | 5.09 | Mkt Cap | 1.00B |
| Vol | 1.34M | Avg Vol | 2.73M | EPS | 0.79 | P/E | 6.41 | Forward P/E | -30.67 |
| Beta | 0.64 | Short Ratio | 13.20 | Inst. Own | 72.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 4.69 | 200-d Avg | 4.48 | 1yr Est | 5.49 |
| Income Statement | |||
| Total Revenue | 1.01M | ||
| Revenues (USD) | 1.01M | ||
| Gross Profit | 1.01M | ||
| Operating Expenses | 6.77M | ||
| Research and Development Expense | 2.90M | ||
| Selling, General and Administrative Expense | 3.87M | ||
| Operating Income | -5.75M | ||
| Interest Expense | 18.00K | ||
| Net Income | -5.14M | ||
| Net Income Common Stock | -5.14M | ||
| Net Income Common Stock (USD) | -5.14M | ||
| Consolidated Income | -5.14M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -5.12M | ||
| Earning Before Interest & Taxes (USD) | -5.12M | ||
| Weighted Average Shares | 197.47M | ||
| Weighted Average Shares Diluted | 197.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.17M | ||
| Cash and Equivalents (USD) | 19.17M | ||
| Investments | 73.45M | ||
| Investments Current | 73.45M | ||
| Trade and Non-Trade Receivables | 179.74M | ||
| Current Assets | 273.88M | ||
| Property, Plant & Equipment Net | 10.00K | ||
| Total Assets | 274.02M | ||
| Debt Current | 514.00K | ||
| Total Debt | 3.63M | ||
| Current Liabilities | 3.36M | ||
| Debt Non-Current | 3.11M | ||
| Total Liabilities | 15.29M | ||
| Accumulated Retained Earnings (Deficit) | -1.22B | ||
| Accumulated Other Comprehensive Income | -48.24M | ||
| Shareholders Equity | 258.73M | ||
| Shareholders Equity (USD) | 258.73M | ||
| Assets Non-Current | 142.00K | ||
| Total Debt (USD) | 3.63M | ||
| Liabilities Non-Current | 11.93M | ||
| Trade and Non-Trade Payables | 2.85M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.00K | ||
| Net Cash Flow from Financing | 3.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.53M | ||
| Issuance (Purchase) of Equity Shares | 3.15M | ||
| Net Cash Flow from Investing | -1.66M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1.66M | ||
| Net Cash Flow from Operations | -6.02M | ||
| Effect of Exchange Rate Changes on Cash | -4.00K | ||
| Share Based Compensation | 1.63M | ||